Vanessa Edmunds

Kearny Venture Partners (Kearny Venture Partners) is a venture capital firm. The firm is headquartered in San Francisco, California.

Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA.

Bairex Medical is a company based in San Francisco, CA.

Treos Bio Ltd. engages in the development of a digital cancer vaccine technology platform that provides tailored precision vaccines to patients. It focuses on cancer immunotherapies. The company was founded by john Kenneth Hautman and Julianna Lisziewicz in 2013 and is headquartered in London, the United Kingdom.

Proxenia Venture Partners LLC (Proxenia Venture Partners) is a venture capital firm founded in 2016 by Menghis Bairu. The firm is headquartered in wilmington, Delaware.

Part of Prothena Corp. Plc, Prothena Therapeutics Ltd. is an Irish nonprofit company located in Dublin that provides business services.

Speranza Therapeutics, Inc. distributes and clinically supports innovative drugs and medical devices requiring FDA approval or clearance. Speranza Therapeutics is based in Boca Raton, FL, and the CEO of the private company is Sal J. Rafanelli. The company targets patients whose chronic illnesses and debilitating conditions are not being effectively addressed. The company offers a non-invasive treatment called S.T. Genesis to manage opioid withdrawal symptoms. This FDA-cleared medical device reduces the physical and emotional strain of withdrawal experienced by those suffering.

Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.

Fremont Health Corp. provides healthcare services. It specializes in the areas of cancer care, diabetes care, business health and maternity care. The company was founded in 1940 and is headquartered in Fremont, NE.

Feather Invest (Feather Invest) is a private equity firm founded in 2015. The firm is headquartered in Cairo, Egypt.

National Technology Enterprises Co (NTEC) is a private equity/venture capital firm founded in 2002. The firm is headquartered in Kuwait City, Kuwait.

Kuwait Life Sciences Co. (KLSC) is a private equity/venture capital subsidiary of National Technology Enterprises Co founded in 2010 by Qais Marafie. The firm is headquartered in Kuwait City, Kuwait.

Clinart FZ LLC operates as a full–service clinical research organization. It offers clinical operations, clinical data management, biostatistics and medical writing, quality and training, regulatory support, and staffing services. The company was founded by Maha Mahmoud Al Farhan in 2001 and is headquartered in Dubai, the United Arab Emirates.

Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA.

Alltracel Pharmaceuticals Plc conducts biopharmaceutical research and development. The firm also markets toothbrushes and dental floss through Butler and Gum brands. It develops products for the wound care and dental care markets. The company was founded in 1996 by Anthony Richardson and Gerard Brandon and is headquartered in Sallynoggin, Ireland.

A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA.

Tekla Capital Management LLC is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts. Formerly known as Hambrecht & Quist Capital Management LLC, the firm serves as an investment adviser for four closed-end funds – Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund.

Viewray Technologies, Inc. develops radiation therapy technology for the treatment of cancer. It operates through the MRIdian system software. The company was founded by James F. Dempsey and Russell S. Donda in March 2004 and is headquartered in Oakwood Village, OH.

Wellpartner LLC engages in the provision of pharmacy services. It offers 340B program management. It provides a seamless, easy-to-use solution for covered entities currently or considering participating in the 340B Drug Program. The company was founded by Michael W. Wright and Robert Judge in November 1998 and is headquartered in Tualatin, OR.

Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH.

Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN.

AliveCor, Inc. develops mobile heart monitoring system. It offers kardia mobile that provides people with suspected or diagnosed heart conditions, and those at risk of heart conditions. The company was founded by David E. Albert, Bruce Satchwell, and Kim Barnett and is headquartered in San Francisco, CA.

Calvert Capital Management Co. (Calvert Capital Management) is a venture capital firm founded in 1982. The firm is headquartered in Waltham, Massachusetts.

Kearny Venture Partners LP invests in US healthcare companies operating in the fields of medical devices and drugs (small molecules & biopharmaceuticals). The fund invests in the range of $10 - $15 million per company with an initial investment of $2 - $8 million. It provides financing for seed, early & later-stage capital requirements.

Aadi Subsidiary, Inc. engages in biopharmaceutical company. Its therapeutic programs include pulmonary arterial hypertension, pediatric solid tumors, solid tumors with mTOR activation and mitochondrial disease. The company was founded by Neil Desai and is headquartered in Pacific Palisades, CA.